Commercialization Strategy

Commercial Lag Is Costing You More Than a Second Hire Ever Would

Susan Nichols

Published on: 11/07/2026

Commercial lag is one of the most expensive hidden problems in life sciences companies. Learn why commercial success in CGT requires both deal execution and market positioning — and why one commercial hire is often not enough.

Commercialization StrategyCell and Gene Therapy

The Readiness Illusion: Escaping Commercial Gravity

Susan Nichols

Published on: 10/07/2026

In today’s Cell and Gene Therapy market, scientific differentiation alone is no longer enough. Learn why CGT companies must build commercial authority early — and how positioning, visibility, and market trust drive long-term commercial success.

Commercialization StrategyCell and Gene Therapy

Escaping Commercial Gravity

Susan Nichols

Published on: 11/05/2026

The science behind Cell and Gene Therapy is advancing rapidly, but commercialization systems are lagging behind. Discover how “Commercial Gravity” prevents breakthrough therapies from reaching patients — and what CGT companies can do to overcome it.

Commercialization StrategyCell and Gene Therapy